These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28418172)

  • 21. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study.
    Uberall MA; Mueller-Schwefe GH; Terhaag B
    Curr Med Res Opin; 2012 Oct; 28(10):1617-34. PubMed ID: 22970658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.
    Rauck RL; Nalamachu S; Wild JE; Walker GS; Robinson CY; Davis CS; Farr SJ
    Pain Med; 2014 Jun; 15(6):975-85. PubMed ID: 24517082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
    Portenoy RK; Messina J; Xie F; Peppin J
    Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain.
    Hale ME; Zimmerman TR; Eyal E; Malamut R
    J Opioid Manag; 2015; 11(6):507-18. PubMed ID: 26728648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Analgesic and Other Pain-Relief Drugs to Manage Chronic Low Back Pain: Results from a National Survey.
    Gouveia N; Rodrigues A; Ramiro S; Eusébio M; Machado PM; Canhão H; Branco JC
    Pain Pract; 2017 Mar; 17(3):353-365. PubMed ID: 27206719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does long-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing.
    Wang H; Fischer C; Chen G; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Physician; 2012 Jul; 15(3 Suppl):ES135-43. PubMed ID: 22786452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study.
    Baron R; Martin-Mola E; Müller M; Dubois C; Falke D; Steigerwald I
    Pain Pract; 2015 Jun; 15(5):455-70. PubMed ID: 24738609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.
    Nalamachu S; Hale M; Khan A
    J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA; Vaughn B; Lagasse S; O'Connor M
    Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose conversion between tapentadol immediate and extended release for low back pain.
    Etropolski MS; Okamoto A; Shapiro DY; Rauschkolb C
    Pain Physician; 2010; 13(1):61-70. PubMed ID: 20119464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic treatment In patients with chronic low back pain and Modic changes (the AIM study): study protocol for a randomised controlled trial.
    Storheim K; Espeland A; Grøvle L; Skouen JS; Aßmus J; Anke A; Froholdt A; Pedersen LM; Haugen AJ; Fors T; Schistad E; Lutro O; Marchand GH; Kadar T; Vetti N; Randen S; Nygaard ØP; Brox JI; Grotle M; Zwart JA
    Trials; 2017 Dec; 18(1):596. PubMed ID: 29246188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is low-dose amitriptyline effective in the management of chronic low back pain? Study protocol for a randomised controlled trial.
    Urquhart DM; Wluka AE; Sim MR; van Tulder M; Forbes A; Gibson SJ; Arnold C; Fong C; Anthony SN; Cicuttini FM
    Trials; 2016 Oct; 17(1):514. PubMed ID: 27770809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component.
    Yousef AA; Al-deeb AE
    Anaesthesia; 2013 Mar; 68(3):260-6. PubMed ID: 23384256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the carrier frequency of interferential current on pain modulation and central hypersensitivity in people with chronic nonspecific low back pain: A randomized placebo-controlled trial.
    Corrêa JB; Costa LO; Oliveira NT; Lima WP; Sluka KA; Liebano RE
    Eur J Pain; 2016 Nov; 20(10):1653-1666. PubMed ID: 27150263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
    Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
    Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Managing" the Placebo Effect: The Single-Blind Placebo Lead-in Response in Two Pain Models.
    Harden RN; Saracoglu M; Connolly S; Kirsling A; Comstock K; Khazey K; Gerson T; Burns J
    Pain Med; 2016 Dec; 17(12):2305-2310. PubMed ID: 28025364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diazepam Is No Better Than Placebo When Added to Naproxen for Acute Low Back Pain.
    Friedman BW; Irizarry E; Solorzano C; Khankel N; Zapata J; Zias E; Gallagher EJ
    Ann Emerg Med; 2017 Aug; 70(2):169-176.e1. PubMed ID: 28187918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone.
    Nalamachu S; deLeon-Casasola OA; Robinson CY; Galer BS; Gould E; Gammaitoni A
    Pain Med; 2015 Dec; 16(12):2338-43. PubMed ID: 26301791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability and efficacy of tapentadol extended release in elderly patients ≥ 75 years of age with chronic osteoarthritis knee or low back pain.
    Biondi DM; Xiang J; Etropolski M; Moskovitz B
    J Opioid Manag; 2015; 11(5):393-403. PubMed ID: 26535967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.